Related Experiment Videos
Thienopyridines: effects on cultured endothelial cells
B Ziemianin1, R Olszanecki, W Uracz
1Jagiellonian University Medical College, Cracow, Poland.
Summary
Thienopyridines, like ticlopidine and clopidogrel, stimulate nitric oxide (NO) and prostacyclin (PGI2) release from cultured endothelial cells. This occurs independently of their anti-platelet effects and may involve increased intracellular calcium levels.
Area of Science:
- Endothelial cell biology
- Pharmacology
- Cardiovascular research
Background:
- Endothelial cells play a crucial role in regulating vascular tone and platelet aggregation.
- Thienopyridines are antiplatelet agents widely used in cardiovascular disease management.
- The in vitro effects of thienopyridines on endothelial cells, particularly regarding vasodilator release, require further elucidation.
Purpose of the Study:
- To investigate the effects of ticlopidine and clopidogrel on nitric oxide (NO) and prostacyclin (PGI2) generation in cultured endothelial cells.
- To examine the role of intracellular calcium ([Ca2+]i) in mediating these endothelial responses.
- To compare the effects of thienopyridines with a known calcium ionophore.
Main Methods:
- Cultured human umbilical vein endothelial cells (HUVEC) and bovine aorta endothelial cells (BAEC) were treated with ticlopidine, clopidogrel, or calcium ionophore A 23187.
- Nitrite generation (a marker of NO production) and 6-keto-PGF1alpha release (a marker of PGI2 production) were measured.
- Intracellular calcium levels ([Ca2+]i) were monitored using fluorescence microscopy.
- Cell viability was assessed after treatment.
Main Results:
- Ticlopidine and clopidogrel significantly increased nitrite and 6-keto-PGF1alpha generation in HUVEC and BAEC.
- Calcium ionophore A 23187 also stimulated NO and PGI2 release, with a more rapid onset than ticlopidine.
- Both ticlopidine and clopidogrel caused a rise in [Ca2+]i, although the effect was less pronounced and slower compared to A 23187.
- Aspirin pretreatment inhibited the ticlopidine-induced increase in 6-keto-PGF1alpha release.
- Cell viability was not affected by the tested concentrations of thienopyridines or A 23187.
Conclusions:
- Thienopyridines, including ticlopidine and clopidogrel, directly stimulate the release of NO and PGI2 from cultured endothelial cells in vitro.
- These effects are independent of their known ex vivo anti-platelet activity.
- A rise in intracellular calcium ([Ca2+]i) may be involved in mediating the endothelial actions of thienopyridines, though this mechanism requires further confirmation.